• Explore /
  • Poster
  • / Efficacy of trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (MBC) previously treated with pertuzumab (P).

Efficacy of trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (MBC) previously treated with pertuzumab (P).

Abstract Poster

Authors

null

Ander Urruticoechea

Onkologikoa Foundation, San Sebastian, Spain

Ander Urruticoechea , Seock-Ah Im , Montserrat Munoz , Jose Baselga , Denise A. Yardley , Sarah Heeson , Sarah Jones , Adam Knott , Hannah Douthwaite , Tanja Badovinac Crnjevic , Sandra M. Swain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

HER2-Positive

Clinical Trial Registration Number

NCT00567190, NCT01026142

Citation

J Clin Oncol 35, 2017 (suppl; abstr 1023)

DOI

10.1200/JCO.2017.35.15_suppl.1023

Abstract #

1023

Poster Bd #

15

Abstract Disclosures

Similar Posters

First Author: Giuseppe Curigliano

First Author: Ander Urruticoechea

First Author: Carey K. Anders

First Author: Hope S. Rugo